NCT02286557View on ClinicalTrials.gov

Testing the Effects of Methylphenidate on Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2025

Study Completion Date

March 4, 2025

Conditions

Fatigue in Multiple Sclerosis

Interventions

DRUG

Methelphenidate

All participants will undergo 4 weeks of treatment with Methelphenidate and 4 weeks of placebo

DRUG

Placebo

Trial Locations (1)

07936

Kessler Foundation, East Hanover

Sponsors

Lead Sponsor

Kessler Foundation

All Listed Sponsors

lead

Kessler Foundation

OTHER